跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 79,176 条关于
“dopaminergic progenitor therapy”
全部
79,176
临床试验
55,153
药物
4,684
机构
117
资讯
19,222
10个月前
BrainXell's BXT-110 Shows Promising Preclinical Results for Parkinson's Disease Cell Therapy
4个月前
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program with FDA Fast Track Status
8个月前
iRegene's NouvNeu001 Becomes First iPSC Therapy to Receive Both FDA Fast Track and RMAT Designations for Parkinson's Disease
去年
iRegene Therapeutics Raises $40M Series B+ Following FDA Fast Track Designation for Parkinson's Cell Therapy
去年
FDA Approves XellSmart's iPSC-Derived Cell Therapies for Parkinson's Disease and ALS Clinical Trials
12个月前
Cerevance Reports Positive Phase 2 Results for Novel Non-Dopaminergic Parkinson's Treatment Solengepras
5个月前
Neural Progenitor Cell Transplants Show Promise for Spinal Cord Repair Through Motor Circuit Reconnection
去年
BlueRock Therapeutics Advances Bemdaneprocel to Phase III for Parkinson's Disease as Market Projected to Reach $7.0 Billion by 2033
3个月前
Transplanted Neural Progenitor Cells Survive One Year in Retinitis Pigmentosa Patients, Phase 1/2a Trial Shows
6个月前
XellSmart Secures Fourth Consecutive FDA and NMPA Approval for iPSC Cell Therapy Targeting Rare Neurodegenerative Disease MSA-P
第 1 页，共 1923 页
上一页
下一页
